Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (241-250 of 310) with videos related to

Pageof 31
Sort By:
Nature Communications|November 1, 2022
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signalingLee Shaashua, Aviad Ben-Shmuel, Meirav Pevsner-Fischer, et al.
Cancer Discovery|September 1, 2022
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing CohortKanika Arora, Thinh N Tran, Yelena Kemel, et al.
Nature Medicine|January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survivalAnna M Varghese, Maria A Perry, Joanne F Chou, et al.
Cancer Discovery|December 20, 2024
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian CarcinomaTanjina Kader, Jia-Ren Lin, Clemens B Hug, et al.
The Journal of Clinical Investigation|September 5, 2019
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinomaAllen S Ho, Angelica Ochoa, Gowtham Jayakumaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate CancerAndrew T Lenis, Vignesh Ravichandran, Samantha Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Coaltered <i>Ras/B-raf</i> and <i>TP53</i> Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal CancerJashodeep Datta, J Joshua Smith, Walid K Chatila, et al.
JCO Precision Oncology|October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate CancerDavid R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Cancer Cell|April 21, 2023
Genomic mapping of metastatic organotropism in lung adenocarcinomaHarry B Lengel, Brooke Mastrogiacomo, James G Connolly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation SequencingHira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.
Pageof 31

Showing results (241-250 of 310) with videos related to

Sort By:
Pageof 31
Nature Communications|November 1, 2022
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signalingLee Shaashua, Aviad Ben-Shmuel, Meirav Pevsner-Fischer, et al.
Cancer Discovery|September 1, 2022
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing CohortKanika Arora, Thinh N Tran, Yelena Kemel, et al.
Nature Medicine|January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survivalAnna M Varghese, Maria A Perry, Joanne F Chou, et al.
Cancer Discovery|December 20, 2024
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian CarcinomaTanjina Kader, Jia-Ren Lin, Clemens B Hug, et al.
The Journal of Clinical Investigation|September 5, 2019
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinomaAllen S Ho, Angelica Ochoa, Gowtham Jayakumaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate CancerAndrew T Lenis, Vignesh Ravichandran, Samantha Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Coaltered <i>Ras/B-raf</i> and <i>TP53</i> Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal CancerJashodeep Datta, J Joshua Smith, Walid K Chatila, et al.
JCO Precision Oncology|October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate CancerDavid R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Cancer Cell|April 21, 2023
Genomic mapping of metastatic organotropism in lung adenocarcinomaHarry B Lengel, Brooke Mastrogiacomo, James G Connolly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation SequencingHira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.
Pageof 31